MyOsteoTeam

Aclasta (also known as zoledronic acid or Reclast) is a bisphosphonate given as a once-yearly IV infusion for osteoporosis. It's one of the most convenient options since you only need it once a year!

Typically, treatment continues for around 3 to 6 years, depending on your fracture risk and how your bones respond. After Show Full Answer

Aclasta (also known as zoledronic acid or Reclast) is a bisphosphonate given as a once-yearly IV infusion for osteoporosis. It's one of the most convenient options since you only need it once a year!

Typically, treatment continues for around 3 to 6 years, depending on your fracture risk and how your bones respond. After that period, a doctor may recommend a "drug holiday" — a temporary break from the medication.

However, taking a break does come with some important considerations:

- Fracture risk can increase during a drug holiday, particularly in years 4 and 5 of the break
- Older patients and those with lower bone density are at higher risk during a holiday
- Bone mineral density should be monitored regularly during any break
- Treatment may need to resume if fracture risk increases

The right number of infusions really depends on your individual situation, bone density scores, and overall fracture risk. It's worth having a detailed conversation with your doctor about when — or whether — a drug holiday makes sense for you.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

7 Treatment Options for Osteoporosis

Bone Drug 'Holiday' May Raise Fracture Risk